|
|
| | An Innovation Agenda for Addiction (recursiveadaptation.com) | | 2 points by toomuchtodo on Dec 23, 2024 | past | 1 comment | |
| | Drinking alcohol reduces the body's natural GLP-1 activity by 34% (recursiveadaptation.com) | | 51 points by comova on Oct 11, 2024 | past | 22 comments | |
| | Reporters ordered $3,600 of fentanyl precursors online, enough for $3M fentanyl (recursiveadaptation.com) | | 6 points by Bluestein on Aug 13, 2024 | past | 1 comment | |
| | First randomized trial of Ozempic for alcoholism shows big drops in drinking (recursiveadaptation.com) | | 83 points by comova on June 17, 2024 | past | 81 comments | |
| | The Market Failure That Will Force Doctors to Keep Writing Opioid Prescriptions (recursiveadaptation.com) | | 2 points by comova on June 5, 2024 | past | |
| | Wegovy and Ozempic (semaglutide) associated with reduction in alcohol addiction (recursiveadaptation.com) | | 76 points by henryaj on June 3, 2024 | past | 162 comments | |
| | The Growing Scientific Case for Using GLP-1s to Treat Addiction (recursiveadaptation.com) | | 2 points by toomuchtodo on June 3, 2024 | past | 2 comments | |
| | The growing scientific case for using Ozempic and other GLP-1s to stop addiction (recursiveadaptation.com) | | 1 point by comova on May 14, 2024 | past | 1 comment | |
| | We are underfunding R&D for addiction by 95% (recursiveadaptation.com) | | 3 points by comova on May 12, 2024 | past | |
|
Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact
|
